Cited 0 times in 
Cited 1 times in 
Effect of beta 3-adrenoceptor agonist on the micromotion of bilateral major pelvic ganglion-excised rat bladder
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Son, Hee Seo | - |
| dc.contributor.author | Moon, Soo Young | - |
| dc.contributor.author | Kwon, Joonbeom | - |
| dc.contributor.author | Kim, Jang Hwan | - |
| dc.date.accessioned | 2023-03-27T02:43:17Z | - |
| dc.date.available | 2023-03-27T02:43:17Z | - |
| dc.date.created | 2023-06-23 | - |
| dc.date.issued | 2023-02 | - |
| dc.identifier.issn | 0733-2467 | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/193678 | - |
| dc.description.abstract | Aims Micromotion is an autonomous intramural movement of the bladder, and is believed to be an initial step in the generation of urinary urgency. Therefore, controlling micromotion may be a novel target in overactive bladder (OAB) treatment. However, developing micromotion treatment has been limited by the absence of a standardized animal model. We attempted to create a micromotion animal model and investigated the effectiveness of a beta(3)-adrenoceptor agonist (CL316,243) on micromotion.Methods Bilateral major pelvic ganglia (MPGs) were excised in 18 male Sprague-Dawley rats, resulting in an almost completely denervated bladder. On postoperative Day 7, cystometry was performed. Rats were divided into three treatment groups: CL316,243; beta(3-)adrenoceptor antagonist (SR59230A) pretreated CL316,243; and a nonselective antimuscarinic agent (oxybutynin). Changes in micromotion were evaluated after the intra-arterial administration of each agent.Results Low-amplitude oscillations in intravesical pressure (micromotion) were observed 1 week after MPGs excision. Micromotion frequency significantly (p = 0.003) decreased (2.17 & PLUSMN; 3.54 times/5 min) with CL316,243 compared with vehicle (6.33 & PLUSMN; 1.97 times/5 min). Micromotion amplitude also decreased with CL316,243 (1.15 & PLUSMN; 1.93 cmH(2)O) compared with vehicle (5.96 & PLUSMN; 5.12 cmH(2)O), approaching conventional significance (p = 0.090). No significant decreases in frequency or amplitude were observed with oxybutynin treatment.Conclusions Systemic administration of the beta(3)-adrenoceptor agonist CL316,243 effectively controlled micromotion in bilateral MPGs-excised, almost completely denervated rat bladders. This result indicates that beta(3)-adrenoceptor agonist may affect the bladder directly, suggesting that it might be effective for overall OAB, regardless of the presence or level of neurological deficits. Bilateral MPGs-excised rats are considered a plausible micromotion animal model suitable for future research. | - |
| dc.description.statementOfResponsibility | restriction | - |
| dc.language | English | - |
| dc.publisher | Alan R. Liss | - |
| dc.relation.isPartOf | Neurourology and Urodynamics | - |
| dc.relation.isPartOf | NEUROUROLOGY AND URODYNAMICS | - |
| dc.rights | CC BY-NC-ND 2.0 KR | - |
| dc.title | Effect of beta 3-adrenoceptor agonist on the micromotion of bilateral major pelvic ganglion-excised rat bladder | - |
| dc.type | Article | - |
| dc.contributor.college | College of Medicine (의과대학) | - |
| dc.contributor.department | Dept. of Urology (비뇨의학교실) | - |
| dc.contributor.googleauthor | Son, Hee Seo | - |
| dc.contributor.googleauthor | Moon, Soo Young | - |
| dc.contributor.googleauthor | Kwon, Joonbeom | - |
| dc.contributor.googleauthor | Kim, Jang Hwan | - |
| dc.identifier.doi | 10.1002/nau.25127 | - |
| dc.relation.journalcode | J02341 | - |
| dc.identifier.eissn | 1520-6777 | - |
| dc.identifier.pmid | 36633527 | - |
| dc.subject.keyword | beta 3-adrenoceptor agonist | - |
| dc.subject.keyword | major pelvic ganglion | - |
| dc.subject.keyword | micromotions | - |
| dc.subject.keyword | models | - |
| dc.subject.keyword | animal | - |
| dc.subject.keyword | neurons | - |
| dc.subject.keyword | afferent | - |
| dc.subject.keyword | overactive bladder | - |
| dc.subject.keyword | urinary bladder | - |
| dc.contributor.alternativeName | Kim, Jang Hwan | - |
| dc.contributor.affiliatedAuthor | Son, Hee Seo | - |
| dc.contributor.affiliatedAuthor | Kim, Jang Hwan | - |
| dc.identifier.scopusid | 2-s2.0-85146339120 | - |
| dc.identifier.wosid | 000912542200001 | - |
| dc.citation.volume | 42 | - |
| dc.citation.number | 2 | - |
| dc.citation.startPage | 530 | - |
| dc.citation.endPage | 538 | - |
| dc.identifier.bibliographicCitation | Neurourology and Urodynamics, Vol.42(2) : 530-538, 2023-02 | - |
| dc.identifier.rimsid | 79824 | - |
| dc.type.rims | ART | - |
| dc.description.journalClass | 1 | - |
| dc.description.journalClass | 1 | - |
| dc.subject.keywordAuthor | beta 3-adrenoceptor agonist | - |
| dc.subject.keywordAuthor | major pelvic ganglion | - |
| dc.subject.keywordAuthor | micromotions | - |
| dc.subject.keywordAuthor | models | - |
| dc.subject.keywordAuthor | animal | - |
| dc.subject.keywordAuthor | neurons | - |
| dc.subject.keywordAuthor | afferent | - |
| dc.subject.keywordAuthor | overactive bladder | - |
| dc.subject.keywordAuthor | urinary bladder | - |
| dc.subject.keywordPlus | NON-VOIDING ACTIVITY | - |
| dc.subject.keywordPlus | BETA(3)-ADRENOCEPTOR AGONIST | - |
| dc.subject.keywordPlus | DETRUSOR OVERACTIVITY | - |
| dc.subject.keywordPlus | AFFERENT ACTIVITY | - |
| dc.subject.keywordPlus | URINARY | - |
| dc.subject.keywordPlus | PATHOPHYSIOLOGY | - |
| dc.subject.keywordPlus | DYSFUNCTION | - |
| dc.subject.keywordPlus | MODULATION | - |
| dc.subject.keywordPlus | MIRABEGRON | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
| dc.relation.journalResearchArea | Urology & Nephrology | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.